Aquaculture AMPs
Fish Diseases
DevelopmentActive
Key Facts
About Numaferm
Numaferm is a Hamburg-based biotech firm operating at the intersection of synthetic biology and biologics production. The company has developed two core technology platforms: Numascreen™ for high-diversity phage display-based lead discovery and Numatech™ for high-titer, cost-effective microbial expression. With an ISO 9001:2015 certified operation and a team of ~30 experts, Numaferm serves as a service provider and partner for pharmaceutical, agricultural, and industrial clients, aiming to democratize access to peptide and protein-based solutions. Its business model combines fee-for-service projects with technology licensing and process development partnerships.
View full company profileTherapeutic Areas
Other Fish Diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| Aquaculture Therapeutics | Elanco | Development/Registration |